Literature DB >> 8387132

A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

W R Welches1, K B Brosnihan, C M Ferrario.   

Abstract

The discovery of angiotensin-(1-7) [Ang-(1-7)] as a bioactive Ang II fragment of the renin-angiotensin system (RAS) alters the current understanding of the enzymatic components that comprise the RAS cascade. Two neutral endopeptidases, prolyl endopeptidase (E.C. 3.4.21.26) and neutral endopeptidase 24.11 (E.C. 3.4.24.11), are capable of forming Ang-(1-7) from Ang I and have been implicated in the in vivo processing of Ang I. This makes them putative Ang processing enzymes and part of the RAS cascade. This review summarizes the physical characteristics and distribution of angiotensin converting enzyme (E.C. 3.4.15.1), a known Ang I processing enzyme, and compares its features to what is known of prolyl endopeptidase and neutral endopeptidase 24.11.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387132     DOI: 10.1016/0024-3205(93)90108-f

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  59 in total

1.  Catalysis of serine oligopeptidases is controlled by a gating filter mechanism.

Authors:  V Fülöp; Z Szeltner; L Polgár
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

Review 2.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 3.  Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

Authors:  Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

4.  High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.

Authors:  Preethi Samuel; Quaisar Ali; Rifat Sabuhi; Yonnie Wu; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-16

5.  Mass spectrometry for the molecular imaging of angiotensin metabolism in kidney.

Authors:  Nadja Grobe; Khalid M Elased; David R Cool; Mariana Morris
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 6.  ACE2: more of Ang-(1-7) or less Ang II?

Authors:  Carlos M Ferrario
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

Review 7.  An evolving story of angiotensin-II-forming pathways in rodents and humans.

Authors:  Carlos Maria Ferrario; Sarfaraz Ahmad; Sayaka Nagata; Stephen W Simington; Jasmina Varagic; Neal Kon; Louis Joseph Dell'italia
Journal:  Clin Sci (Lond)       Date:  2014-04       Impact factor: 6.124

Review 8.  Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).

Authors:  Sarfaraz Ahmad; Carlos M Ferrario
Journal:  Expert Opin Ther Pat       Date:  2018-10-10       Impact factor: 6.674

9.  Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; Jessica L VonCannon; Norihito Moniwa; K Bridget Brosnihan; Jan Wysocki; Daniel Batlle; Carlos M Ferrario
Journal:  Am J Hypertens       Date:  2013-03-04       Impact factor: 2.689

Review 10.  Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.

Authors:  Carlos M Ferrario
Journal:  Life Sci       Date:  2009-12-01       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.